Sun Pharmaceutical shares fell by 4.6% to an intraday low of Rs 1,626.50 on the BSE on Friday after the drug major reported a 20% year-on-year decline in consolidated net profit to Rs 2,278 crore for Q1FY26, compared to Rs 2,836 crore in the same quarter last year.
Comments
Post a Comment